share_log

Sensus Healthcare Analyst Ratings

Sensus ヘルスケアアナリストの評価

Benzinga ·  2023/11/13 10:25
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/13/2023 312.37% HC Wainwright & Co. → $8 Reiterates Buy → Buy
08/07/2023 312.37% HC Wainwright & Co. $10 → $8 Maintains Buy
05/04/2023 415.46% HC Wainwright & Co. $16 → $10 Reiterates → Buy
05/04/2023 260.82% Alliance Global Partners $14.5 → $7 Maintains Buy
02/10/2023 724.74% HC Wainwright & Co. → $16 Reiterates → Buy
02/10/2023 647.42% Alliance Global Partners $16.5 → $14.5 Maintains Buy
11/04/2022 750.52% Alliance Global Partners $17.5 → $16.5 Maintains Buy
05/06/2022 724.74% HC Wainwright & Co. $13 → $16 Maintains Buy
03/03/2022 570.1% HC Wainwright & Co. $12 → $13 Maintains Buy
02/14/2022 518.56% HC Wainwright & Co. $10 → $12 Maintains Buy
12/02/2021 415.46% HC Wainwright & Co. $9 → $10 Maintains Buy
11/05/2021 363.92% HC Wainwright & Co. $7 → $9 Maintains Buy
08/06/2021 260.82% HC Wainwright & Co. $6 → $7 Maintains Buy
03/01/2021 209.28% HC Wainwright & Co. $4 → $6 Maintains Buy
02/26/2021 209.28% Roth Capital $4 → $6 Maintains Buy
11/09/2020 106.19% HC Wainwright & Co. $5 → $4 Maintains Buy
05/11/2020 54.64% B. Riley Securities $5.5 → $3 Maintains Neutral
05/08/2020 157.73% HC Wainwright & Co. $8 → $5 Reiterates → Buy
11/07/2019 183.51% B. Riley Securities $14 → $5.5 Downgrades Buy → Neutral

What is the target price for Sensus Healthcare (SRTS)?

The latest price target for Sensus Healthcare (NASDAQ: SRTS) was reported by HC Wainwright & Co. on November 13, 2023. The analyst firm set a price target for $8.00 expecting SRTS to rise to within 12 months (a possible 312.37% upside). 6 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Sensus Healthcare (SRTS)?

The latest analyst rating for Sensus Healthcare (NASDAQ: SRTS) was provided by HC Wainwright & Co., and Sensus Healthcare reiterated their buy rating.

When is the next analyst rating going to be posted or updated for Sensus Healthcare (SRTS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensus Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensus Healthcare was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.

Is the Analyst Rating Sensus Healthcare (SRTS) correct?

While ratings are subjective and will change, the latest Sensus Healthcare (SRTS) rating was a reiterated with a price target of $0.00 to $8.00. The current price Sensus Healthcare (SRTS) is trading at is $1.94, which is within the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする